Navigation Links
Accuray to Showcase Clinical Utilization and Adoption of its Latest Advanced Product Platforms at ASTRO 2013
Date:9/22/2013

m number of treatments allowing us to minimize side effects and preserve our patients' quality of life," said Jeffrey S. Eshleman, M.D., Director of Radiation Oncology, Ann B. Barshinger Cancer Institute of Lancaster General Health in Pennsylvania. "We are focused on providing the most effective and efficient SRS/SBRT treatment option and the CyberKnife System has excelled in its ability to track and treat moving targets while sparing nearby critical structures and healthy tissue."

"In its first three months of clinical use at our center, the TomoHDA System has proven to be a versatile and efficient addition to our department," said Prof. Eric Lartigau, M.D., Ph.D., Centre Oscar Lambret, Lille, France. "The system allows rapid treatment planning and high-precision dose delivery, a combination of features that lends itself well to breast cancer cases and helps improve overall quality, patient throughput and workflow for the department."

"In an effort to enhance the capabilities of the TomoTherapy and CyberKnife Systems, our guiding mission is always to provide patients with the best possible treatment outcomes," said Joshua H. Levine, president and chief executive officer of Accuray. "The feedback we have received from leading radiation oncology practitioners validates the decision to further invest in our unique product offerings. We look forward to our invaluable collaborators informing colleagues of their experiences and learnings to-date at this year's ASTRO meeting."

There will be many opportunities to learn about Accuray's advanced radiation oncology treatment solutions at the 2013 ASTRO annual meeting, including:

Clinical research presentations:  Clinical presentations will be delivered in scientific sessions highlighting clinical outcomes obtained with real-time tracking of target motion a
'/>"/>

SOURCE Accuray Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Accuray Incorporated CFO Resigns
2. Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
3. Accuray Announces Results for Fourth Quarter and Fiscal Year 2013
4. Accuray to Host Investor Meeting at ASTRO 2013
5. Accuray to Report Financial Results for Fourth Quarter and Year End Fiscal 2013
6. Accuray is Honored for Delivering World-Class Customer Service
7. Accuray Incorporated to Present at 2013 Jefferies Global Healthcare Conference
8. Accuray Announces Results for Third Quarter Fiscal 2013
9. Accuray Incorporated to Report Financial Results for Third Quarter Fiscal 2013
10. Accuray Provides Clarification on Recently Initiated Voluntary Recalls
11. Dr. Emad Rizk Joins Accuray Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... -- goBalto, Inc., the leading provider of cloud-based clinical study ... Red Herring,s Top 100 Global award. goBalto ... in 2013, marking its emergence as a top player ... Top 100 Global list has become a mark of ... Herring editors were among the first to recognize that ...
(Date:11/26/2014)... , Nov. 25, 2014  Medtronic,s roughly ... has been widely discussed in the media for ... creating a stronger leading player in one of ... Information.  The healthcare market research firm said  the ... feature a diverse set of solutions spanning inpatient ...
(Date:11/26/2014)... Heska Corporation (NASDAQ: HSKA ) - ( ... advanced veterinary diagnostic and other specialty veterinary products , announced ... The Benchmark Company, LLC,s Micro Cap Discovery Conference on Thursday, ... The Palmer House Hilton, 17 E. Monroe Street, ... Please email hska@haydenir.com or contact your Benchmark representative ...
Breaking Medicine Technology:goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Heska to Attend Benchmark Micro Cap Discovery Conference 2
... ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces that positive ... of ZIO-201 (isophosphoramide mustard,- IPM) to treat ... Society of Medical Oncology (ESMO) meeting held ... entitled, "Phase-I/II,Study of IPM (ZIO-201) In Advanced ...
... - TransPharma Medical,Ltd., a specialty pharmaceutical company ... products utilizing a proprietary,active transdermal drug delivery ... I clinical trials demonstrating the,safety and pharmacokinetic ... treatment of osteoporosis., A seven day, repeated ...
Cached Medicine Technology:Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 2TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 3
(Date:11/26/2014)... HealthDay Reporter WEDNESDAY, Nov. ... their dogs understand what they,re saying, a new study suggests ... a human-like way. Past research has shown that dogs ... actual content and the emotional tone, said study author Victoria ... into the canine brain, according to Ratcliffe, a Ph.D. candidate ...
(Date:11/26/2014)... The report “Laboratory Information System/LIS Market by Type ... User Labs (Clinical, Molecular Diagnostic, Blood Bank, Anatomic ... Forecast to 2019” provides a detailed overview of ... trends, and strategies impacting the LIS market along ... and market growth. , Browse 85 market data ...
(Date:11/26/2014)... Increasing incidence rate of adverse ... are expected to be prime pharmacovigilance market growth ... acute and chronic ailments has resulted in a ... Moreover, growing adverse drug reaction related hospitalization rates, ... the need of the hour in the pharmaceutical ...
(Date:11/26/2014)... DC (PRWEB) November 26, 2014 For ... (AIS) independently published The AIS Report on Blue Cross ... and WellPoint, Inc. on the varied strategies the two ... and improve compliance with treatments for sleep apnea, ranging ... sleep disorder, because it’s linked to increased rates of ...
(Date:11/26/2014)... Howell, NJ (PRWEB) November 26, 2014 ... issues,” and Florida-based SeniorNet, a nonprofit organization providing the ... have teamed up to help seniors navigate the rough ... will focus on educating seniors on the topic of ... through the somewhat complicated process of applying for this ...
Breaking Medicine News(10 mins):Health News:Your Dog Really Is Listening to You 2Health News:Your Dog Really Is Listening to You 3Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 2Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 3Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2
... of Life-threatening Infection in,Healthcare Facilities, WASHINGTON, ... Infection Control and Epidemiology (APIC) today announced,a ... The initiative begins with the first national ... the spread of this virulent pathogen., ...
... Cleaner Future, Study Finds Zero-Emission Vehicles Can Avoid,Health Costs From Premature ... ... Impacts, SACRAMENTO, Calif., March 20 ... California, $142 billion in,human health and global warming reduction benefits would ...
... March 20 NHS Choices ( http://www.nhs.uk ), ... new Live well bundle aimed to,help people improve ... information, the Fitness section,( http://www.nhs.uk/Livewell/fitness/Pages/fitnesshome.aspx ) enables users,to ... of exercise in seconds and,provides them with clinically ...
... The administrative,organization model of choice for most ... team or functional leaders rather,than to a ... surveyed indicate current administrative staffing levels as ... reported any plans for,administrative staffing reductions, according ...
... worms are shedding new light on the hormone,s role in ... gained new insight into the workings of insulin, potentially laying ... has only taken place in worms, a common model for ... if it will translate to humans. But worms whose insulin ...
... In workplaces where nurses are bullied, the quality ... and the retention of quality nurses becomes difficult. A ... & Neonatal Nursing reviews the psychological and social issues ... creating a respectful work environment. , More than ...
Cached Medicine News:Health News:APIC Launches First National C. Difficile Prevalence Study 2Health News:New Lung Association Study Shows $142 Billion Benefit of Converting to Zero-Emission Vehicles by 2030 2Health News:New Lung Association Study Shows $142 Billion Benefit of Converting to Zero-Emission Vehicles by 2030 3Health News:New Lung Association Study Shows $142 Billion Benefit of Converting to Zero-Emission Vehicles by 2030 4Health News:Admins Support 65% More Pharma Operations Execs than Rule-of-Thumb Dictates 2Health News:Tweaking Insulin Might Help Fight Aging 2
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... is a rapid ELISA test for Clostridium ... value and 99% sensitivity. That means the ... out C. difficile negatives - which can ... before culturing for the organism - and ...
... is a rapid immunoassay to detect Clostridium difficile ... test uses antibodies specific for toxins A and ... and >99% specificity compared to tissue culture. Because ... B, the risk of false negative results due ...
Medicine Products: